Africa's drug regulator: from treaty to traction

15 January 2026

What started as a pan-African treaty push is now a staffed regulator with a Kigali address and early procedures already being tested. 

The African Medicines Agency (AMA) was adopted by the African Union in 2019 and its treaty entered into force in 2021. By 2026, 31 countries had ratified it. Rwanda's capital proudly hosts AMA’s headquarters, which became operational in late 2024.

The AMA’s first director-general, Dr Delese Mimi Darko, previously led Ghana’s national medicines regulator. External support helped convert the political project into working processes. The European Medicines Agency (EMA) provided funding and technical guidance, while the World Health Organization (WHO) supported the design of pilot procedures.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight



More Features in Pharmaceutical